TSHA — TAYSHA GENE THERAPIES INC

Ownership history in Virtu Financial LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Virtu Financial LLC reported a position in TAYSHA GENE THERAPIES INC (TSHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.01%
First filed
2023 Q1
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 48,123 -59,421 -55.3% 0.01% $157K $3.27
2024 Q4 ADDED 107,544 +50,353 +88.0% 0.01% $186K $1.73
2024 Q2 ADDED 57,191 +31,121 +119.4% 0.01% $128K $2.24
2023 Q4 REDUCED 26,070 -19,389 -42.7% 0.00% $46K $1.77
2023 Q1 INITIATED 45,459 — — 0.00% $36K $0.80
% of Fund (quarterly)    TSHA price (monthly, adj. close)

Other funds also holding TSHA

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.31% Octagon Capital Advisors LP 3Y 5.92% GordonMD Global Investments LP 5.25% SUPERSTRING CAPITAL MANAGEMENT LP 2.89% Ally Bridge Group (NY) LLC 3Y 2.86% Ally Bridge Group (NY) LLC 3Y 2.62% Vestal Point Capital, LP 2.57% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Siren, L.L.C. 1.66% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.33%
← Back to Virtu Financial LLC Holdings